Article
[Epigenetic dysregulation in myelodysplastic syndrome].
[Rinsho ketsueki] The Japanese journal of clinical hematology - 1 Feb 2015
Sashida Goro, Iwama Atsushi
Abstract excerpt
Myelodysplastic syndrome (MDS) is a clonal hematopoietic stem cell disease characterized by impaired hematopoiesis and an increased risk of transformation to acute myeloid leukemia. Various epigenetic regulators are mutated in MDS patients, indicating that accumulation of epigenetic alterations together with genetic alterations plays a crucial role in the development of MDS.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
